Tag Archives: OREX

Top Clean Energy Stocks To Buy Right Now

To get rich, you have to be making money while you’re asleep.– David Bailey

Investors in stocks should absolutely love this quote, because stocks can make you filthy rich, provided you can find ones that have stood the tests of time and can continue to do so, without your having to constantly check on them. It could be a company’s dominance and moat(s) in a growing industry, or its focus on the next megatrend — if it can capitalize on the opportunities, you should be able to earn solid returns.

Right now, I believe Mastercard (NYSE:MA), Brookfield Renewable Partners(NYSE:BEP), and XPO Logistics(NYSE:XPO) fall right into place, because each stock has been a multibagger and has strong tailwinds behind it.

Brookfield Renewable Partners: A bet on the clean energy megatrend

Clean energy is one big trend that’s gradually taking shape, and companies that have already dived into alternative sources of energy should be major beneficiaries. Brookfield Renewable Partners is a fine example.

Top Clean Energy Stocks To Buy Right Now: SPDR S&P MidCap 400 ETF (MDY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Sei Investments Co. increased its position in shares of SPDR S&P MidCap 400 ETF (NYSEARCA:MDY) by 84.3% in the 1st quarter, Holdings Channel reports. The firm owned 1,686 shares of the exchange traded fund’s stock after purchasing an additional 771 shares during the quarter. Sei Investments Co.’s holdings in SPDR S&P MidCap 400 ETF were worth $576,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    PNC Financial Services Group Inc. trimmed its holdings in SPDR S&P MidCap 400 ETF (NYSEARCA:MDY) by 1.9% during the 1st quarter, Holdings Channel reports. The firm owned 1,139,465 shares of the exchange traded fund’s stock after selling 22,647 shares during the period. PNC Financial Services Group Inc.’s holdings in SPDR S&P MidCap 400 ETF were worth $389,390,000 as of its most recent filing with the SEC.

  • [By Dan Caplinger]

    Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who’ve been willing to look at smaller companies have seen much stronger returns than those who’ve stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes — SPDR S&P 500 (NYSEMKT:SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT:MDY) for midsize companies, and SPDR S&P SmallCap 600 (NYSEMKT:SLY) for small companies — you can put a number on just how much better smaller stocks have done:

  • [By ]

    Yet when it comes to investing, reward often comes from being willing to take on risk. Over the past 10 years, investors who’ve been willing to look at smaller companies have seen much stronger returns than those who’ve stuck with the tried-and-true big names that are more familiar to them. When you look at exchange-traded funds tracking indexes composed of companies of different sizes SPDR S&P 500 (NYSEMKT: SPY) for large companies, SPDR S&P Midcap 400 (NYSEMKT: MDY) for midsize companies and SPDR S&P SmallCap 600 (NYSEMKT: SLY) for small companies you can put a number on just how much better smaller stocks have done:

Top Clean Energy Stocks To Buy Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about Orexigen Therapeutics (NASDAQ:OREX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Orexigen Therapeutics earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media headlines about the biopharmaceutical company an impact score of 45.6752029162772 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

Top Clean Energy Stocks To Buy Right Now: Container Store (TCS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Container Store Group Inc (NYSE:TCS)’s share price hit a new 52-week high and low during mid-day trading on Monday . The company traded as low as $6.55 and last traded at $6.44, with a volume of 109163 shares. The stock had previously closed at $6.21.

  • [By Joseph Griffin]

    COPYRIGHT VIOLATION NOTICE: “Zacks: Analysts Anticipate Container Store Group Inc (TCS) Will Post Quarterly Sales of $231.21 Million” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this story can be accessed at www.tickerreport.com/banking-finance/3377830/zacks-analysts-anticipate-container-store-group-inc-tcs-will-post-quarterly-sales-of-231-21-million.html.

  • [By Motley Fool Staff]

    The Container Store Group (NYSE:TCS) Q4 2017 Earnings Conference CallMay. 22, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Clean Energy Stocks To Buy Right Now: United Bankshares Inc.(UBSI)

Advisors’ Opinion:

  • [By ]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , American Airlines (AAL) , Align Technology (ALGN) , Procter & Gamble (PG) , United Bankshares (UBSI) , Valeant Pharmaceuticals (VRX) and Dominion Energy (D) .

Top Clean Energy Stocks To Buy Right Now: Patriot Transportation Holding, Inc.(PATI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Patriot Transportation Holding Inc (NASDAQ:PATI) VP John D. Milton, Jr. sold 5,601 shares of the business’s stock in a transaction that occurred on Thursday, June 14th. The shares were sold at an average price of $22.51, for a total value of $126,078.51. Following the sale, the vice president now owns 402 shares in the company, valued at $9,049.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Top 10 Medical Stocks For 2019

Small cap regenerative medicine stock RepliCel Life Sciences (OTCQB: REPCF; CVE: RP) has just reported compelling safety and clinical data from its phase 1/2 tendon repair study investigating the use ofthe Companys type 1 collagen-expressing, hair follicle-derived fibroblasts (RCT-01) as a treatment for Achilles tendinosis. The clinical trial met its goal of establishing a complete safety profile at 6 months. More importantly, there wereno serious adverse events related to the study treatment or injection procedure.

Tendinosis, sometimes called chronic tendinitis, chronic tendinopathy or chronic tendon injury, is damage to a tendon at a cellular level that is thought to be caused by microtears in the connective tissue in and around the tendon. This leads toan increase in tendon repair cells. The incidence of tendon injury increases with age and it’s especially common after age 40 while some medical conditions can increase the risk (including arthritis, gout and thyroid disorders).

Top 10 Medical Stocks For 2019: B. Riley Financial, Inc.(RILY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Broadridge Financial Solutions (NYSE: BR) and B. Riley Financial (NASDAQ:RILY) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends.

  • [By WWW.GURUFOCUS.COM]

    For the details of Standard General L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

    These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 12,576,000 shares, 60.53% of the total portfolio. New PositionTime Inc (TIME) – 3,181,424 shares, 29.62% of the total portfolio. Turning Point Brands Inc (TPB) – 305,319 shares, 3.58% of the total portfolio. Shares added by 189.90%CafePress Inc (PRSS) – 2,500,000 shares, 3.12% of the total portfolio. New PositionB. Riley Financial Inc (RILY) – 167,736 shares, 1.97% of the total portfoli

Top 10 Medical Stocks For 2019: The NASDAQ OMX Group Inc.(NDAQ)

Advisors’ Opinion:

  • [By Sean Williams]

    However, Canada becoming the first developed country in the world to legalize adult-use cannabis is far from the only “marijuana first” we’ve witnessed this year. In February, Canadian weed investment company Cronos Group (NASDAQ:CRON), which has three core assets, announced that it was becoming the first Canadian pot stock to uplist to the Nasdaq (NASDAQ:NDAQ). Moving from the over-the-counter (OTC) exchange to a more reputable exchange like the Nasdaq allowed for improved liquidity, as well as cleared the way for institutional investors to take a position in Cronos Group. Wall Street traditionally shies away from investing in OTC-listed companies.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nasdaq (NDAQ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    ILLEGAL ACTIVITY NOTICE: “$644.24 Million in Sales Expected for Nasdaq Inc (NDAQ) This Quarter” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at www.tickerreport.com/banking-finance/3374974/644-24-million-in-sales-expected-for-nasdaq-inc-ndaq-this-quarter.html.

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

Top 10 Medical Stocks For 2019: Treehouse Foods, Inc.(THS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of TreeHouse Foods (NYSE:THS) have been assigned an average rating of “Hold” from the twenty-one research firms that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, thirteen have given a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $49.75.

  • [By Stephan Byrd]

    State of New Jersey Common Pension Fund D reduced its holdings in TreeHouse Foods (NYSE:THS) by 40.0% during the 1st quarter, Holdings Channel reports. The institutional investor owned 240,000 shares of the company’s stock after selling 160,000 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in TreeHouse Foods were worth $9,185,000 as of its most recent SEC filing.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on TreeHouse Foods (THS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on TreeHouse Foods (THS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks For 2019: Microvision Inc.(MVIS)

Advisors’ Opinion:

  • [By Max Byerly]

    IMPINJ (NASDAQ: PI) and MicroVision (NASDAQ:MVIS) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, risk, valuation, institutional ownership, analyst recommendations and earnings.

Top 10 Medical Stocks For 2019: Newcastle Investment Corporation(NCT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    PolySwarm (CURRENCY:NCT) traded 3.5% lower against the dollar during the 1 day period ending at 0:00 AM Eastern on June 2nd. PolySwarm has a market cap of $9.94 million and $67,420.00 worth of PolySwarm was traded on exchanges in the last 24 hours. One PolySwarm token can currently be purchased for $0.0068 or 0.00000089 BTC on major exchanges including HitBTC, DDEX and IDEX. In the last week, PolySwarm has traded 8.2% lower against the dollar.

Top 10 Medical Stocks For 2019: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market
  • [By Ethan Ryder]

    These are some of the news stories that may have effected Accern Sentiment’s analysis:

    Get PetroChina alerts:

    PetroChina Company Limited (PTR) Receives Consensus Rating of “Buy” from Analysts (americanbankingnews.com) PetroChina to spend 5.3 bln yuan on Chongqing gas storage: Xinhua (reuters.com) UPDATE: Bernstein Upgrades Petrochina (PTR) to Outperform (streetinsider.com) Kunlun Energy Company Limited — Moody’s changes Kunlun Energy’s outlook to stable from negative (finance.yahoo.com) PetroChina (PTR) Upgraded at Sanford C. Bernstein (americanbankingnews.com)

    Shares of PetroChina traded down $0.85, reaching $82.35, during midday trading on Friday, Marketbeat Ratings reports. The company had a trading volume of 165,409 shares, compared to its average volume of 150,236. The company has a market capitalization of $152.09 billion, a P/E ratio of 46.26 and a beta of 1.43. PetroChina has a 52-week low of $60.69 and a 52-week high of $84.10. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.55 and a current ratio of 0.82.

  • [By Max Byerly]

    ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect PetroChina (PTR) Stock Price” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at www.tickerreport.com/banking-finance/3368551/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-petrochina-ptr-stock-price.html.

Top 10 Medical Stocks For 2019: Technology Select Sector SPDR ETF (XLK)

Advisors’ Opinion:

  • [By Jim Crumly]

    The tech stocks led the market higher today, with theTechnology Select Sector SPDR ETF (NYSEMKT:XLK) posting a gain of 0.6%. Crude oil set a two-year high, and theEnergy Select Sector SPDR ETF (NYSEMKT:XLE) moved up 0.3%.

  • [By Todd Shriber, ETF Professor]

    The new communication services sector will result in the departures of some marquee names from ETFs such as the Consumer Discretionary Select Sector SPDR (NYSE: XLY) and the Technology Select Sector SPDR (NYSE: XLK).

  • [By Jim Crumly]

    Energy was the strongest sector thanks to a 3.7% rise in crude oil futures; theSPDR S&P Oil & Gas Exploration & Production ETF (NYSEMKT:XOP) jumped 4.2%.Tech stocks also rebounded, with theTechnology Select Sector SPDR ETF (NYSEMKT:XLK) gaining 2.5%.

Top 10 Medical Stocks For 2019: Hudson Technologies, Inc.(HDSN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 32 percent to $2.7799 after the company reported downbeat Q1 earnings.

    Commodities

  • [By Lisa Levin]

    Hudson Technologies Inc. (NASDAQ: HDSN) was down, falling around 25 percent to $3.07 after the company reported downbeat Q1 earnings.

    Commodities

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Hudson Technologies (HDSN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks For 2019: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Stephan Byrd]

    Media headlines about Orexigen Therapeutics (NASDAQ:OREX) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Orexigen Therapeutics earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media headlines about the biopharmaceutical company an impact score of 45.6752029162772 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 10 Medical Stocks For 2019: Credit Acceptance Corporation(CACC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Credit Acceptance (NASDAQ: CACC) and Nelnet (NYSE:NNI) are both mid-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

  • [By Logan Wallace]

    Credit Acceptance (NASDAQ:CACC) last posted its earnings results on Thursday, May 3rd. The credit services provider reported $6.11 earnings per share for the quarter, missing the Zacks’ consensus estimate of $6.19 by ($0.08). The company had revenue of $295.60 million for the quarter, compared to analysts’ expectations of $296.16 million. Credit Acceptance had a net margin of 43.49% and a return on equity of 29.44%. The firm’s quarterly revenue was up 12.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.67 EPS. equities research analysts anticipate that Credit Acceptance will post 26.04 EPS for the current fiscal year.

Top 5 Low Price Stocks To Own Right Now

Peyto (OTCPK:PEYUF) is a Canadian E&P company whose production profile is dominated by dry gas (92%). With the low price of natural gas, it has been a tough couple of years for Peyto’s shareholders. That said, the company has maintained its dividend payout through the commodity price downturn. Recently natural gas prices have recovered from their lows, but Peyto’s stock has not kept pace. In fact, it’s gone the other direction:

Click to enlarge

As the chart above show, the stock is down ~13% over the past three months as natural gas – as measure by both the Henry Hub and AECO indexes – has rallied sharply with significant winter withdrawals and forecasts that additional cold weather is on the way:

Top 5 Low Price Stocks To Own Right Now: Ascent Capital Group, Inc.(ASCMA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

  • [By Lisa Levin]

    Tuesday afternoon, the industrial sector proved to be a source of strength for the market. Leading the sector was strength from NL Industries Inc (NYSE: NL) and Ascent Capital Group Inc (NASDAQ: ASCMA).

Top 5 Low Price Stocks To Own Right Now: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Aside from Outperform-rated Roper Technologies (ROP) SaaS platforms, which account for over +50% of earnings today, GEs Digital business strategy is the most ambitious ramp within the industrials sector. GE has made a bold bet on its game-changing Predix operating system for the Industrial IoT, which was launched in Feb-2016

  • [By Ben Levisohn]

    Flexing the barbell strategy to balance Safe Havens with more cyclical exposures. In our view, industrials investors should be positioning their portfolio with a barbell strategy, with half of the exposure in Safe Havens like General Electric, Xylem (XYL), Danaher, Honeywell International, Roper Technologies (ROP), and AMETEK (AME), and the other half selectively in the cyclical names that are better positioned today, such as Pentair, HD Supply Holdings (HDS),Actuant (ATU), Atkore International Group (ATKR), Ingersoll-Rand, and Eaton (ETN). We still believe risk-reward is mostly balanced and that the macro will remain choppy into 2017, supporting a positioning in the defensive names. But if investor sentiment improves on not-worse news and earnings results, the more cyclical names could fare better.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

Top 5 Low Price Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top 5 Low Price Stocks To Own Right Now: FORM Holdings (FH)

Advisors’ Opinion:

  • [By Matthew Briar]

    Looking for a quick, money-making trading idea? Put FORM Holdings Corp. (NASDAQ:FH) on your watchlist, if not yet in your portfolio. FH shares are knocking on the door of a breakout move, and one more nudge could do the trick.

    There are a couple of factors in play here. One of the is the converging wedge pattern that’s developed after the October-December finally stabilized. The upper boundary of that wedge at $2.40 has been tested several times since late last year, but FORM Holdings could never get past the hurdle. At the same time, several key moving average lines seem to be acting as support — even if unevenly — keeping FH positioned well for a breakout effort.

Top 5 Low Price Stocks To Own Right Now: Nature's Sunshine Products, Inc.(NATR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Tuesday. Top gainers in the sector included Nature's Sunshine Prod. (NASDAQ: NATR), Bridgford Foods Corporation (NASDAQ: BRID), and SunOpta, Inc. (USA) (NASDAQ: STKL).

penny stock quotes

In September 2016, privately held tech ‘unicorn’ Apttus (Private:APTUS) raised $88 million in late stage venture capital investment and its CEO has indicated a desire to IPO in 2017.

A ‘unicorn’ is a tech startup that has been valued at or more than $1 billion by private investors.

Founded in 2006 by CEO Kirk Krappe, Apttus has developed a suite of enterprise contract management solutions to streamline the sales and quoting process.

Here’s a brief overview of the company’s approach:

(Source: Apttus)

San Mateo, California-based Apttus, which is backed by investors such as K1 Investment Management, Salesforce (NYSE:CRM), Kuwait Investment Authority, Gulf Islamic Investments, Kia Motors and ICONIQ Capital, has a raised at least $274 million in private investment.

I recently spoke with Chief Revenue Officer Kamal Ahluwalia about the company’s history and future potential.

(The following has been edited for brevity.)

DJ: Apttus operates in the contract management space which is pretty large and dynamic – how would you describe the major technology trends currently impacting the space?

penny stock quotes: Dean Foods Company(DF)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q4 2016 earnings report for small cap Dean Foods Co (NYSE: DF) is scheduledfor before the market opens onThursday (February 16th) with the strongest volume performance seen in yearsbeing reported the last time around.

  • [By Jon C. Ogg]

    Dean Foods Co. (NYSE: DF) was raised to Overweight from Neutral with a $22 price target (versus an $18.75 close) at JPMorgan. Dean Foods has a 52-week range of $15.69 to $22.31 and a consensus analyst price target of $20.17.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Peter Graham]

    A long term performance chart shows shares of WhiteWave Foods peakingtwo summers in a rowwhile mid capThe Hain Celestial Group, Inc (NASDAQ: HAIN) also peaked two summers in a rowandsmall cap Dean Foods Co (NYSE: DF) has been moving a bit higher for the past couple of years:

  • [By Lisa Levin]

    Tuesday afternoon, the non-cyclical consumer goods & services shares climbed by 0.71 percent. Meanwhile, top gainers in the sector included Weight Watchers International, Inc. (NYSE: WTW), up 17 percent, and Dean Foods Co (NYSE: DF), up 6 percent.

  • [By Lisa Levin]

    Dean Foods Co (NYSE: DF) posted weaker-than-expected earnings for its first quarter on Tuesday.

    Dean Foods said it earned $0.13 per share in the first quarter on revenue of $2.00 billion; Analysts were expecting the company to earn $0.18 per share on revenue of $1.097 billion.

penny stock quotes: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Citrix Systems, Inc. (NASDAQ: CTXS) which jumped 6.8% to $84.93. The stocks 52-week range is $59.72 to $87.99. Volume was 5.19 million which is well above the daily average of around 2.09 million shares.

  • [By Ben Levisohn]

    Citrix Systems (CTXS)soared nearly to the top of the S&P 500 today afterreports it had hired Goldman Sachs (GS) to pursue a sale of the company.

    S. MARTIN/AFP/Getty Images

    Citrix Systemsgained 6.8% to $84.93 today, while the S&P 500 finished little changed at 2,373.47.

    Business Insider’s Matt Weinbergerhas the details:

    Citrix, the $13 billion tech company best known for software like GoToMeeting, is working with Goldman Sachs to negotiate a possible sale, reports Bloomberg, citing anonymous sources.

    This isn’t the first time that Citrix has shopped itself around: in late 2015, and under pressure from activist shareholder Elliott Management, Citrix was said to have unsuccessfully tried to find a buyer.

    Citrix Systems market cap rose t0 $13.3 billion today from $12.4 billion on Friday. It reported net income of $536 million on sales of $3.4 billion in 2016.

  • [By Ben Levisohn]

    Wynn Resortsgained 4.8% to $104.30 today, while the S&P 500 finished little changed at2,373.47. At 2:45, Wynn was easily the top performing stock in the S&P 500, only to be surpassed by Citrix’s (CTXS) late day surge.

penny stock quotes: Enphase Energy, Inc.(ENPH)

Advisors’ Opinion:

  • [By Ben Levisohn]

    UPDATE: I stand corrected. There does appear to be a reason for First Solar’s market-leading move today. Axiom Capital’s Gordon Johnson attributes the rise to the $10 million investment in Enphase Energy (ENPH), which makes “microinverter systems for the solar photovoltaic industry,” by investors T.J. Rodgers and John Doerr.

penny stock quotes: ZTE Corporation (ZTCOF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Chinese telco equipment giant ZTE (OTCPK:ZTCOF) has been actively cooperating and communicating with relevant U.S. government departments in order to reach a conclusion of the investigation related to the compny’s violations of sanctions on Iran.

  • [By SEEKINGALPHA.COM]

    The United States has a history of preventing Chinese companies that are even suspected of being state-owned from selling certain products into key industries. Huawei and ZTE (OTCPK:ZTCOF), for example, were under harsh scrutiny for their telecommunications equipment.

penny stock quotes: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

penny stock quotes: Extreme Networks Inc.(EXTR)

Advisors’ Opinion:

  • [By Azam Zariff]

    Extreme Networks, Inc. (NASDAQ: EXTR), a communication company, has been on a surge the past year. From the low of $2.32 to high of $8.11 in just over a year, this stock might continue to rise. Besides the strong financials, and positive acquisition news, EXTR current price is testing the high of $8.11 and once the price breaks above $8.11, we can expect the price to surge.

Top Bank Stocks To Own Right Now

In August 2016, BlackBerry Ltd. (NYSE:BB) filed suit against Avaya Inc. (OTCQX:AVYA) for patent infringement. BlackBerry stated that Avaya was infringing on eight BlackBerry held patents in multiple products.

In January 2017, Avaya filed for Chapter 11 bankruptcy protection, putting a halt to the lawsuit. However, the alleged products were still being sold by the company.

In February 2017, BlackBerry requested that the court lift the stay on the patent suit and the shield of Avaya’s bankruptcy has been cracked in April 2017, granting BB’s application.

On December 15th, few days ago, Avaya emerged from Chapter 11 after completing its debt restructuring, and it is now publicly quoted on OTCMKTS with a market cap of around $8B.

What will it imply for BlackBerry’s lawsuit? Apparently not much: it will keep its ordinary court path, which was allowed to continue in April 2017, after a New York bankruptcy court cracked the protection shield of Avaya’s Chapter 11.

Top Bank Stocks To Own Right Now: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Top Bank Stocks To Own Right Now: Halliburton Company(HAL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Halliburton (HAL) : “I liked Halliburton’s analyst day, but I think Schlumberger (SLB) is even better.”

    Noble Energy (NBL) : “Noble’s good. It’s a very well-run, conservative company. It should do well in this environment.”

  • [By Ben Levisohn]

    Halliburton (HAL) has gotten beaten up this year…and even today’s earnings beat doesn’t capable of reversing its fortunes.

    Getty Images

    Halliburton reported a profit of 4 cents, beating forecasts for 3 cents, on sales of $4.28 billion, narrowly edging expectations for $4.27 billion. Halliburton’s shares were trading higher before the market opened, but have declined have declined 0.3% to $46.90 at 1:56 p.m. today.

    Evercore ISI’s James West sees a “margin explosion” coming for Halliburton during the second half of the year, while comparing the oil-services giant to LeBron:

    With the start of the year already regarded as a transition period, we view the companys decision to sacrifice near term margins in order to accelerate long-term profitability and revenue growth as a defensive, yet calculated, and preemptive maneuver. Execution does remain a risk but naysayers seem to utter similar indecencies about LeBron James each year as the playoffs arrive. You dont doubt the king, and HAL is the clear market leader when it comes to NAM completions, in our view. The change in HALs reporting format makes syncing HALs commentary with its financials more difficult, but NAM comprised 68% and 61% of C&P revenues in 2014 and 2015, respectively (71% and 21% of EBIT). As such, the broader segment should be a good proxy for the region. Abatement of cost inflation, or at least a deceleration as we progress beyond the first step-change in activity of the cycle should serve as an additional tailwind for margins. The most likely benefit will come from proppant costs as sand mines resume processing finer mesh grades following the winter hiatus. Additional frac capacity is being reactivated at leading edge prices, evidenced by the fact that incremental margins improved throughout the first quarter, and the company continues to repair legacy contracts and commitments. The improvement of the broader po

  • [By Lisa Levin]

    Halliburton Company (NYSE: HAL) reported better-than-expected earnings for its first quarter on Monday.

    Halliburton posted adjusted earnings of $0.04 per share in the quarter on revenue of $4.28 billion; Analysts were expecting the company to earn $0.03 per share on revenue of $4.26 billion.

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

  • [By Lee Jackson]

    These companies also reported insider buying last week: Apache Corp. (NYSE: APA), Halliburton Co. (NYSE: HAL), Revlon Inc. (NYSE: REV), Valeant Pharmaceuticals International Inc. (NYSE: VRX) and U.S. Steel Corp. (NYSE: X).

Top Bank Stocks To Own Right Now: TransUnion(TRU)

Advisors’ Opinion:

  • [By JJ Kinahan]

    Ready To Shop? A highlight this coming week is Black Friday, and recent data hint that shoppers might be ready. A record 195.9 million consumers now have access to revolving credit such as bank-issued and private label credit cards, TransUnion (NYSE: TRU) said in a recent press release. This is the highest level of revolving credit access since TRU began measuring the variable and is greater than the 192.6 million consumers who had access to such credit products in Q3 2016. “The third quarter of 2017 exhibited a lending market that continued to operate in a stable manner, with consumers continuing to gain access to credit and take advantage of that access,” said Ezra Becker, senior vice president and head of research and consulting for TransUnion, in the press release. “However, we are beginning to see a slowdown in originations, which may be a signal of saturation in the lower-risk credit tiers and some pull-back in lender risk appetite in the higher-risk tiers.” Still, Becker predicted a “robust holiday shopping season.”

Top Bank Stocks To Own Right Now: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Top Bank Stocks To Own Right Now: Piedmont Natural Gas Company Inc.(PNY)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    Duke also recently has expanded on its natural gas efforts, and will add numerous more natural gas customers when its buy-out of Piedmont Natural Gas Company, Inc. (PNY) goes through.